Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Subjects With Cancer-Related Pain
NCT00858754 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Subjects With Cancer-Related Pain
- Lead sponsor
- Bausch Health Americas, Inc.
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- March 31, 2009
- Completion date
- August 31, 2009
- Enrollment
- 0 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.